Translating IPF Clinical Trials to Real Life Patients: A Case-Based Symposium

This presentation addresses the following learning objectives:

  • Describe the evidence using triple therapy of NAC to treat IPF
  • Discuss the efficacy, safety, and clinical application of new treatment options for patients with IPF

Luca Richeldi, MD, PhD; Harold R. Collard, MD; Kevin K. Brown, MD; Marilyn K. Glassberg, MD
Prepared for “Translating IPF Clinical Trials to Real Life Patients:
A Case-Based Symposium," May 19, 2015

Download [pdf » 5.5MB]

Access other Therapeutic Areas: